Skip to content
AnalystLens

CISCO SYSTEMS, INC. 8-K Report, Bylaw Amendment (Aug 25, 2025)

Reports
Corporate Changes·Exhibits & Filings
Filing Date
Filed August 25, 2025
Period End
August 21, 2025
Security
CSCO
In the record · 2016–202610-K1110-Q328-K146

CSCO filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 146 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Mar ’17Mar ’17
  2. Restructuring8-K · Aug ’20Aug ’20
  3. Leadership change8-K · Nov ’22Nov ’22
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 8-K filed August 25, 2025. Cited figures are marked; the original filing is the authoritative source.

Cisco Systems, Inc. (CSCO) has filed an 8-K report detailing an amendment to its Amended and Restated Bylaws, effective August 21, 2025.

The primary change introduces a 'cure period' for stockholders submitting director nomination notices. This amendment allows stockholders an opportunity to correct deficiencies in their nomination submissions, provided they are submitted within the designated timeframe outlined in the bylaws. The company also made minor ministerial adjustments for clarity and consistency within the bylaws.

This change is primarily procedural and aims to enhance the shareholder engagement process for director nominations. Investors should note that while this amendment facilitates a smoother nomination process, it does not fundamentally alter Cisco's corporate governance structure or its strategic direction. The full text of the Amended and Restated Bylaws and a version highlighting the changes are available as exhibits to this filing.

Key Highlights

  1. Cisco Systems, Inc. amended its Amended and Restated Bylaws effective August 21, 2025.
  2. Key amendment introduces a 'cure period' for stockholder director nomination notices.
  3. Stockholders will have an opportunity to correct deficiencies in nomination submissions.
  4. The cure process applies to notices submitted within the specified timeframe.
  5. Minor ministerial changes were made for clarification and consistency.
  6. This amendment facilitates a more streamlined director nomination process for shareholders.
  7. Full text of amended bylaws and a marked-up version are available as exhibits.

Frequently Asked Questions

  1. What is the main purpose of the bylaw amendment filed by Cisco?

    The main purpose of the bylaw amendment is to introduce a 'cure period' for stockholders who submit director nomination notices. This means that if a stockholder's nomination notice has certain deficiencies, they will be given an opportunity to correct them, provided the initial notice was submitted within the bylaws' specified timeframe.

  2. How does this amendment affect my ability to nominate a director?

    This amendment makes the process of nominating a director potentially easier for shareholders. If you submit a nomination notice that contains a correctable error, you will now have a chance to fix it before it is formally rejected, which was not explicitly provided for in the previous bylaws.

  3. Are there any financial implications or changes to Cisco's business strategy resulting from this filing?

    No, this 8-K filing is related to corporate governance and procedural matters. The amendment to the bylaws concerns the process for director nominations and does not involve any changes to Cisco's financial statements, business operations, or strategic direction.

  4. Where can I find the details of the new bylaw provisions?

    The full text of the Amended and Restated Bylaws, as amended, is filed as Exhibit 3.2 to this Current Report on Form 8-K. Additionally, a version of the bylaws marked to show the specific changes made against the prior version is attached as Exhibit 3.3.